# Wound Infiltration as Part of an Opioid Free Pain Management Pathway Following Cesarean Delivery

> **NCT03545516** · PHASE2 · UNKNOWN · sponsor: **Richmond University Medical Center** · enrollment: 540 (estimated)

## Conditions studied

- Pain, Postoperative
- Anesthesia, Local
- Opioid Use

## Interventions

- **DRUG:** Bupivacaine
- **DRUG:** Dexmedetomidine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03545516
- **Lead sponsor:** Richmond University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-09-17
- **Primary completion:** 2018-11-01
- **Final completion:** 2018-11-01
- **Target enrollment:** 540 (ESTIMATED)
- **Last updated:** 2018-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03545516

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03545516, "Wound Infiltration as Part of an Opioid Free Pain Management Pathway Following Cesarean Delivery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03545516. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*